Queue Raises $12.6M for Robotic Pharmacy
Analysis based on 8 articles · First reported Jun 30, 2026 · Last updated Jul 06, 2026
The successful funding and launch of Queue's autonomous robotic pharmacy system are expected to positively impact the healthcare and retail pharmacy industries by addressing labor shortages, reducing costs, and improving access to medications. This innovation could lead to increased efficiency and profitability for pharmacy operators, while also enhancing patient convenience and care in the United States.
Queue, a Palo Alto-based startup, has emerged from stealth with its fully autonomous robotic pharmacy system, designed to transform prescription dispensing, verification, and delivery. The company announced an oversubscribed $12.6 million seed round led by Kevin P. Ryan, bringing its total funding to $18.6 million, including a previous $6 million pre-seed round led by VSR Ventures Private Limited. Additional investors include House Capital, VSR Ventures Private Limited, VSR Ventures Private Limited, and Banter Capital. Queue's system operates autonomously, taking sealed wholesale pill bottles and producing filled, verified prescription vials, supporting 250-280 of the most prescribed medications in the United States. The company claims its system can deliver medications at up to 96% lower cost than traditional pharmacies and aims to address critical issues like labor shortages, cost pressures, and pharmacy deserts in the American healthcare system. Queue has already secured a major national pharmacy chain as a customer and deployed a working prototype. The funding will be used to accelerate product development, expand deployments, and grow its engineering team. Co-founded by CEO Nick Desai and CTO Josh Liu, Queue is positioning autonomous prescription fulfillment as a new infrastructure layer for American healthcare.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard